Dynamics & Trends in Molecular Interaction Analysis: After-Work Networking Event by Creoptix and 2BindEvent-Datum: 01.12.2021
5pm – 7pm GMT at Auditorium, Wagistrasse 25
Expert in kinetics, Dr. Thomas Schubert from 2Bind, will discuss the importance of reliable molecular binding characterization in antibody and small molecule development. Dr. Kaspar Cottier, founder of Creoptix and developer of the label-free GCI technology, will clarify the basis of the technology behind the WAVEsystem and illustrate how it is being applied to accelerate discovery. Together, the presenters will highlight the need for robust affinity and kinetics analysis in drug development and discuss the current solutions for life-science researchers.
The event is in person (Zurich – CH) and the number of seats is limited – save your seat today by registering here! More info on the agenda will follow if you register to the event.